Opportunity
T3165 - Naloxone, 4mg Nasal Spray, FDA-Approved, for the New Jersey Department of Human Services
Response due
November 20, 2026
- Buyer
- State of New Jersey
- Agency
- Division of Purchase and Property
- Estimated value
- Not stated
Key dates
- Response due
- November 20, 2026
Who is this buyer
Organization
- HeadquartersNew Jersey
Similar organizations
Matched on type, size band, geography, and facility mix — peers of this organization tend to buy the same things.
Clinic · FORT LEE, NJ · 1 location
- Same state — NJ
Physician Practice · LAKEWOOD, NJ · 50 staffed beds
- Same state — NJ
Clinic · WAYNE, NJ · 95 staffed beds
- Same state — NJ
FQHC / CHC · JERSEY CITY, NJ · 2 locations
- Same state — NJ
Hospital · HAMMONTON, NJ · 515 staffed beds
- Same state — NJ
Hospital · PEMBERTON, NJ · 30 staffed beds
- Same state — NJ
SNF · LAKEWOOD, NJ · 1 location
- Same state — NJ
Physician Practice · WALL TOWNSHIP, NJ · 1 location
- Same state — NJ
Buying history
- Records6 total
- Opportunities / awards4 / 0
- ActiveAugust 14, 2026 – October 15, 2026
What they buy
- Administrative (4)
- Clinical (1)
- Insurance (1)
Also open from this buyer
- T1901 - Telephonic - Tobacco Cessation Counseling (DOH) REBIDDue November 13, 2026 · Administrative
- T2679 - Employee Benefits: Pharmacy Benefits ManagementDue October 30, 2026 · Clinical
- T3076- New Jersey Early Intervention Services (NJEIS)Due December 9, 2026 · Administrative
View source document →
Source link on buyspeed.
Source record
- Buyer type
- State
- Jurisdiction
- New Jersey (NJ)
- Category
- Administrative
- Set-aside
- Not stated
- NAICS
- Not stated
- PSC
- Not stated